Skip to main content
Clinical Trials/NCT04431986
NCT04431986
Unknown
Not Applicable

Association Between Emergency Room Evaluation and Recommendations Tool (ER2) Frailty Levels and Incident Adverse Health Events in Older Community Dwellers: Results of the NuAge Study

Jewish General Hospital0 sites1,741 target enrollmentSeptember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Frailty
Sponsor
Jewish General Hospital
Enrollment
1741
Primary Endpoint
Physical functional decline
Last Updated
5 years ago

Overview

Brief Summary

Older adults' health and functional status are heterogeneous because of the various cumulative effects of chronic diseases and physiologic decline, contributing to a vicious cycle of increased frailty 1-4. Thanks to advances in medicine and hygiene, a growing number of older adults spend more years with a greater range of chronic diseases causing disability but not mortality 5. Health systems need to face this new challenge 4,5. Quantification of frailty and its association with the occurrence of incident adverse health events (i.e., functional decline, unplanned hospitalizations) is crucial to understand how health systems may efficiently respond to this situation 6. This study aims to examine the association of the ER2 tool score and its stratification in three levels for incident adverse health events in older community dwellers and to compare this association with three validity frailty indexes which are the Cardiovascular Health Study (CHS) frailty index, Study of Osteoporotic Fracture (SOF) index and Rockwood frailty index.

Registry
clinicaltrials.gov
Start Date
September 1, 2020
End Date
September 1, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Cyrille Launay

Principal Investigator

Jewish General Hospital

Eligibility Criteria

Inclusion Criteria

  • All enrolled participants of NuAge Study who agreed to be part of the NuAge Database and Biobank for future research purposes

Exclusion Criteria

  • Missing data
  • Participants' refusal to use their data for a purpose not identified during their recruitment.

Outcomes

Primary Outcomes

Physical functional decline

Time Frame: 4 years

annual variation of physical functional score available in the Nuage database

Hospitalizations

Time Frame: 4 years

presence or absence of hospitalizations, information available in the Nuage database

ER2

Time Frame: 4 years

6-item questionnaire determining a stratification of frailty risk in three levels (Low, moderate, high)

SOF index

Time Frame: 4 years

index with 3 items determining a level of frailty from 0 (patient is vigorous) to 1 (patient is pre-frail)

CHS index

Time Frame: 4 years

index with 5 items determining a level of frailty from 0 component positive (patient is vigorous), 1 or 2 positive components (patient is in an intermediate stage) to 3 or more positive components (patients is frail)

Rockwood index

Time Frame: 4 years

index determining a level of frailty from 0 to 17 (less than 5: patient is vigorous, between 6 and 11 patient is apparently vulnerable and above 12 patient is in severe frailty)

Mortality

Time Frame: 4 years

death of the participant, information available in the Nuage database

Falls

Time Frame: 4 years

presence or absence of falls, information available in the Nuage database

Similar Trials